Respiratory
News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
BioMérieux Confirms Full-Year Guidance as Q3 Sales Jump 8 Percent
The firm also slightly lowered its estimates for a negative currency impact on its full-year results guidance.
FDA Clears Qiagen QiaStat-Dx Respiratory Mini Panel
The panel detects influenza A and B, respiratory syncytial virus, SARS-CoV-2, and human rhinovirus.
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
Both firms will develop rapid, home-use diagnostic tests to simultaneously detect SARS-CoV-2, influenza A, and influenza B.
The firm will enter clinical trials in November for a combined flu, RSV, and COVID test and expects to debut additional small syndromic panels later.
BARDA Initiatives Award Approximately $2.8M to Four Diagnostics Developers
The contracts were awarded to Karius, Signature Science, In Diagnostics, and Tufts University through BARDA's Agnostic Diagnostics and Lab at Home initiatives.